Abstract: While the typically-collected diameter data contains information for detecting some garter springs, many garter springs may not be detected without processing the diameter data. Responsively, a method for processing the diameter data to detect the garter springs has been developed. In particular, the processing involves fitting of the diameter data to a shape, determining residual errors and using the residual errors to locate garter springs.

Abstract: There are provided inter alia compounds of formula (I) wherein R1, Ar, L, X, R3 and Q are as defined in the specification for use in therapy, especially in the treatment of inflammatory diseases.

Abstract: The present invention relates to respiratory formulations comprising a compound of formula (I): and use of said compounds and compositions in treatment, for example in the treatment of an inflammatory disease or a respiratory disorder, in particular an inflammatory mediated and/or virally mediated respiratory disorder such as asthma and COPD or the treatment or prevention of viral infection, for example infection by influenza virus, rhinovirus or RSV. The invention also extends to certain novel compounds of formula (I).

Abstract: The present invention relates inter alia to a compound of formula (I) and to compositions comprising the same and to the use of the compounds and to compositions of the compounds in treatment, for example in the treatment of inflammatory diseases, in particular respiratory inflammatory disease. The invention also extends to methods of making the said compounds.

Abstract: There is provided a compound of formula (I) which is an inhibitor of the family of p38 mitogen-activated protein kinase enzymes, and to its use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as asthma and COPD.

Abstract: A training system is disclosed. The training system includes a server. The server includes a processor, data storage, a data input/output interface, and a voice interface. The data input/output interface is configured to provide a web-based interface to a data terminal and to receive, from the data terminal and via the web-based interface, both an identifier identifying at least one voice terminal and at least one response. The voice interface is configured to transmit at least one audio test signal corresponding to at least one audio test to the at least one voice terminal. The response is a response to the at least one audio test. In one embodiment, the voice terminal and the data terminal are combined in a single device.

Abstract: There are provided inter alia compounds of formula (I) wherein R1, Ar, L, X, R3 and Q are as defined in the specification for use in therapy, especially in the treatment of inflammatory diseases.

Abstract: A training system is disclosed. The training system includes a server. The server includes a processor, data storage, a data input/output interface, and a voice interface. The data input/output interface is configured to provide a web-based interface to a data terminal and to receive, from the data terminal and via the web-based interface, both an identifier identifying at least one voice terminal and at least one response. The voice interface is configured to transmit at least one audio test signal corresponding to at least one audio test to the at least one voice terminal. The response is a response to the at least one audio test. In one embodiment, the voice terminal and the data terminal are combined in a single device.

Abstract: A phased array ultrasonic probe may be mounted to a component to be inspected for wall thickness on an apparatus that includes a split ring adapted to be magnetically held in place on the component. In particular, the probe may be mounted to a carriage connected to the split ring in a manner that allows the carriage to rotate around the split ring while the probe is in operation. Between the probe and the component, a transducer shoe defining, by a flexible membrane, a cavity and an aperture. Conveniently, the construction of the flexible membrane allows wall thickness measurements to be acquired in portions of the component that have complex topography, such as welds. The apparatus is installed on an adaptor assembly for inspection of straight section of pipes. This adaptor assembly is not used in absence of straight section.

Abstract: There are provided compounds of formula I, wherein R, R1, Ra, Rb, Q, X and Y have meanings given in the description, which compounds have antiinflammatory activity (e.g. through inhibition of one or more of members of: the family of p38 mitogen-activated protein kinase enzymes; Syk kinase; and members of the Src family of tyrosine kinases) and have use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, eye and intestines.

Abstract: A method, system and program product, the method comprising: accessing Transfer Fee data to be paid to a third party that is not the borrower or the lender or the buyer or seller in a repurchase agreement transaction of a security for a right to loan or repo one or more units of the security; accessing data on a loan or repo of units of the security, calculating an amount of a Transfer Fee for the right to loan or repo the security; generating data for debiting an account or sending a bill for the Transfer Fee; and updating the database with data on the Transfer Fee.

Abstract: There are provided inter alia compounds of formula (I) wherein R1, Ar, L, X, R3 and Q are as defined in the specification for use in therapy, especially in the treatment of inflammatory diseases.

Abstract: A method, system and program product, the method comprising: accessing Transfer Fee data to be paid to a third party that is not the borrower or the lender of a security for a right to loan one or more units of the security; accessing loan data on a loan of units of the security, calculating an amount of a Transfer Fee for the right to loan the security; generating data for debiting an account or sending a bill for the Transfer Fee; sending or having sent data on revenue from one or more of the Transfer Fees to be paid to an issuer of the security; updating the database with data on the Transfer Fee.

Abstract: The present invention relates to respiratory formulations comprising a compound of formula (I): and use of said compounds and compositions in treatment, for example in the treatment of an inflammatory disease or a respiratory disorder, in particular an inflammatory mediated and/or virally mediated respiratory disorder such as asthma and COPD or the treatment or prevention of viral infection, for example infection by influenza virus, rhinovirus or RSV. The invention also extends to certain novel compounds of formula (I).

Abstract: A method, system and program product, the method comprising: accessing Transfer Fee data to be paid to a third party that is not the borrower or the lender of a security for a right to loan one or more units of the security; accessing loan data on a loan of units of the security, calculating an amount of a Transfer Fee for the right to loan the security; generating data for debiting an account or sending a bill for the Transfer Fee; sending or having sent data on revenue from one or more of the Transfer Fees to be paid to an issuer of the security; updating the database with data on the Transfer Fee.

Abstract: A bill 3 or stiffening member for a bill for headwear 1, such as a baseball cap, having first and second opposed surfaces and including a retaining means 9 arranged to automatically retain the bill in either of a first curved state in which the first side of the bill is convex and the second side concave and a second, oppositely, curved state in which the first side is concave and the second side is convex when the bill it urged towards the first or second states respectively. The retaining means may be a curved, resilient, elongate member such as a rod 9. The retaining means may be secured to a flexible sheet of material 6. The sheet of material may also be resilient.

Abstract: A training system is disclosed. The training system includes a server. The server includes a processor, data storage, a data input/output interface, and a voice interface. The data input/output interface is configured to provide a web-based interface to a data terminal and to receive, from the data terminal and via the web-based interface, both an identifier identifying at least one voice terminal and at least one response. The voice interface is configured to transmit at least one audio test signal corresponding to at least one audio test to the at least one voice terminal. The response is a response to the at least one audio test. In one embodiment, the voice terminal and the data terminal are combined in a single device.

Abstract: There is provided a compound of formula (I): wherein: J represents (A): or (B): compositions comprising same, processes for preparing said compounds and use thereof in treatment, particularly in the treatment of inflammatory disease, such as asthma, COPD and 15 rheumatoid arthritis.

Abstract: There is provided inter alia a compound of formula (I): wherein R1, J, Ar, L, X, R3 and R4 are as defined in the specification, for use in the treatment of inflammatory disorders.

Abstract: There are provided inter alia compounds of formula (I): wherein R1, R2a, R2b, R3, R4, L, X, R5 and R6 are as defined in the description for use in the treatment of inflammatory diseases.